At a glance
ClinicalIndex Comparison RecordN/ACompleted· 69 enrolled
Drug / intervention
Alcohol vs. Placeboother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized, Double-Blind, Placebo-Based Study to Determine Effect of Evening Alcohol on Sympathetic Neural Activity and Baroreflex Function in Binge Drinkers
In Brief
A clinical study evaluating Alcohol vs. Placebo for Binge Drinking. Completed, enrolled 69 participants across 1 site.
Detailed Summary
This study evaluates the impact of evening alcohol consumption on sympathetic activity and baroreflex function in binge drinkers. Our central hypothesis is that evening binge alcohol consumption will lead to sympathetic overactivity and blunted baroreflex function.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBinge Drinking
CountriesUnited States
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartMay 2018
First PostedJun 2018
Primary CompletionJul 2022
TodayJul 2026
First PostedJun 25, 2018
Enrollment StartMay 21, 2018
Primary CompletionJul 1, 2022
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 8.0 years ago
Interventions
Alcohol vs. Placeboother
Using a randomized, cross-over design, all subjects will consume evening alcohol (and a fluid-control placebo) in a dose that mimics binge drinking.